{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:01:12Z","timestamp":1789984872897,"version":"4.0.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1038\/ajg.2011.156","type":"journal-article","created":{"date-parts":[[2011,5,10]],"date-time":"2011-05-10T07:59:00Z","timestamp":1305014340000},"page":"1638-1645","source":"Crossref","is-referenced-by-count":221,"title":["High-Dose Ursodeoxycholic Acid Is Associated With the Development of Colorectal Neoplasia in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis"],"prefix":"10.14309","volume":"106","author":[{"given":"John E","family":"Eaton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina G","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell S","family":"Pardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Sinakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris V","family":"Kowdley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velimir A C","family":"Luketic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwyn M","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"McCashland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex S","family":"Befeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Harnois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Petz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith D","family":"Lindor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210210","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0889-8553(05)70065-0","article-title":"Cancer risk in patients with inflammatory bowel disease.","volume":"28","author":"Lewis","year":"1999","journal-title":"Gastroenterol Clin N Am"},{"key":"R2-14-20210210","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1155\/2008\/824168","article-title":"Primary sclerosing cholangitis.","volume":"22","author":"Silveira","year":"2008","journal-title":"Can J Gastroenterol"},{"key":"R3-14-20210210","first-page":"1285","article-title":"The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis.","volume":"92","author":"Marchesa","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"R4-14-20210210","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for treatment of primary sclerosing cholangitis.","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"R5-14-20210210","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","article-title":"Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis Ursodoexycholic Acid Study Group.","volume":"336","author":"Lindor","year":"1997","journal-title":"N Engl J Med"},{"key":"R6-14-20210210","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1053\/gast.2001.27965","article-title":"A preliminary trial of high dose ursodoexycholic acid in primary sclerosing cholangitis.","volume":"121","author":"Mitchell","year":"2001","journal-title":"Gastroenterology"},{"key":"R7-14-20210210","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1572-0241.2001.03777.x","article-title":"High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis.","volume":"96","author":"Harnois","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R8-14-20210210","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/01635580701883003","article-title":"Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer: roles of ras, p38, and ccaatenhancer-binding protein.","volume":"60","author":"Khare","year":"2008","journal-title":"Nutr Cancer"},{"key":"R9-14-20210210","first-page":"1684","article-title":"Enrichment of the more hydrophilic bile acid ursodeoxycholic acid in the fecal water-soluble fraction after feeding to rats with colon cancer polyps.","volume":"58","author":"Batta","year":"1998","journal-title":"Cancer Res"},{"key":"R10-14-20210210","first-page":"5257","article-title":"Mechanism of action of chemoprotective ursodeoxycholate in the azoxymethane model of colon carcinogenesis: potential roles of protein kinase C-, -II, and -.","volume":"55","author":"Wall","year":"1995","journal-title":"Cancer Res"},{"key":"R11-14-20210210","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/0016-5085(95)90750-5","article-title":"The site-specific delivery of ursodeoxycholic acid to the rat colon by sulfate conjugation.","volume":"9","author":"Rodrigues","year":"1995","journal-title":"Gastroenterology"},{"key":"R12-14-20210210","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/jn\/134.2.483","article-title":"Ursodeoxycholic acid (UDCA) can inhibit deoxcholic acid (DCA) induced apoptosis via modulation of EGFRRAF-1ERK signaling in human colon cancer cells.","volume":"134","author":"Im","year":"2004","journal-title":"J Nutr"},{"key":"R13-14-20210210","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-134-2-200101160-00008","article-title":"Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.","volume":"134","author":"Tung","year":"2001","journal-title":"Ann Intern Med"},{"key":"R14-14-20210210","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2003.50156","article-title":"Ursodeoxycholic acid as a chemopreventative agent in patients with ulcerative colitis and primary sclerosing cholangitis.","volume":"124","author":"Pardi","year":"2003","journal-title":"Gastroenterology"},{"key":"R15-14-20210210","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1365-2036.2005.02650.x","article-title":"The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis.","volume":"22","author":"Wolf","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R16-14-20210210","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis.","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"R17-14-20210210","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ajg.2009.727","article-title":"The Practice Parameters Committee of the American College of Gastroenterology. Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee.","volume":"105","author":"Kornbluth","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R18-14-20210210","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0046-8177(83)80175-0","article-title":"Dysplasia in inflammatory bowel disease: standard classification with provisional clinical applications.","volume":"14","author":"Riddell","year":"1983","journal-title":"Hum Pathol"},{"key":"R19-14-20210210","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0016-5085(99)70279-9","article-title":"Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps.","volume":"117","author":"Rubin","year":"1999","journal-title":"Gastroenterology"},{"key":"R20-14-20210210","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0016-5085(99)70278-7","article-title":"Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis.","volume":"117","author":"Engelsgjerd","year":"1999","journal-title":"Gastroenterology"},{"key":"R21-14-20210210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hep.23631","article-title":"Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: relation to disease progression.","volume":"52","author":"Sinakos","year":"2010","journal-title":"Hepatology"},{"key":"R22-14-20210210","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jb\/mvi106","article-title":"Characteristics of apoptosis in HCT116 colon cancer cells induced by deoxycholic acid.","volume":"138","author":"Yui","year":"2005","journal-title":"J Biochem"},{"key":"R23-14-20210210","first-page":"3774","article-title":"Effects of diet on fecal excretion and bacterial modification of acidic and neutral steroids, and implications for colon carcinogenesis.","volume":"41","author":"Kay","year":"1981","journal-title":"Cancer Res"},{"key":"R24-14-20210210","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0959-8049(95)00216-6","article-title":"Role of bile acids in colorectal carcinogenesis.","volume":"31","author":"Nagengast","year":"1995","journal-title":"Eur J Cancer"},{"key":"R25-14-20210210","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.3748\/wjg.15.3329","article-title":"Bile acids as endogenous etiologic agents in gastrointestinal cancer.","volume":"15","author":"Bernstein","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R26-14-20210210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/10715769709097792","article-title":"Secondary bile acid induced DNA damage in HT29 cells: are free radicals involved?","volume":"26","author":"Booth","year":"1997","journal-title":"Free Radic Res"},{"key":"R27-14-20210210","first-page":"2792","article-title":"Requirements for induction of DNA strand breaks by lithocholic acid.","volume":"42","author":"Kulkarni","year":"1982","journal-title":"Cancer Res"},{"key":"R28-14-20210210","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/carcin\/bgl139","article-title":"Deoxycholate induces mitochondrial oxidative stress and activates NF-kappaB through multiple mechanisms in HCT-116 colon epithelial cells.","volume":"28","author":"Payne","year":"2007","journal-title":"Carcinogenesis"},{"key":"R29-14-20210210","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.mrrev.2004.08.001","article-title":"Bile acids as carcinogens in human gastrointestinal cancers.","volume":"589","author":"Bernstein","year":"2005","journal-title":"Mutat Res"},{"key":"R30-14-20210210","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/0016-5085(92)90162-R","article-title":"Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and bile drainage.","volume":"102","author":"Walker","year":"1992","journal-title":"Gastroenterology"},{"key":"R31-14-20210210","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0016-5085(19)31871-2","article-title":"Metabolism of ursodeoxycholic acid in man.","volume":"73","author":"Fedorowski","year":"1977","journal-title":"Gastroenterology"},{"key":"R32-14-20210210","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF02773728","article-title":"Conversion of 7-ketolithocholic acid to ursodeoxycholic acid by human intestinal anaerobic microorganisms: interchangeability of chenodeoxycholic acid and ursodeoxycholic acid.","volume":"14","author":"Higashi","year":"1979","journal-title":"Gastroenterol Jpn"},{"key":"R33-14-20210210","doi-asserted-by":"crossref","first-page":"6740","DOI":"10.1038\/sj.onc.1205729","article-title":"Bile acids stimulate invasion and haptotaxis in human colorectal cancer cells through activation of multiple oncogenic signaling pathways.","volume":"21","author":"Debruyne","year":"2002","journal-title":"Oncogene"},{"key":"R34-14-20210210","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2009.08.030","article-title":"Lithocholic acid upregulates uPAR and cell invasiveness via MAPK and AP-1 signaling in colon cancer cells.","volume":"290","author":"Baek","year":"2010","journal-title":"Cancer Lett"},{"key":"R35-14-20210210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/bbrc.2000.2899","article-title":"Bile acids reduce the apoptosis effects of sodium butyrate on human colon adenoma (AAC1) cells: implications for colon carcinogenesis.","volume":"273","author":"McMillan","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"R36-14-20210210","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/j.gastro.2009.12.037","article-title":"AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease.","volume":"138","author":"Farraye","year":"2010","journal-title":"Gastroenterology"},{"key":"R37-14-20210210","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1572-0241.2002.05610.x","article-title":"The fate of low grade dysplasia in ulcerative colitis.","volume":"97","author":"Ullman","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R38-14-20210210","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2036.2007.03241.x","article-title":"Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis.","volume":"25","author":"Thomas","year":"2007","journal-title":"Aliment Pharmacol Ther"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2011156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2011156","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2011156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201109000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:36:05Z","timestamp":1786541765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201109000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2011.156","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}